A detailed history of Fmr LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Fmr LLC holds 21,161,285 shares of MRNA stock, worth $1.16 Billion. This represents 0.17% of its overall portfolio holdings.

Number of Shares
21,161,285
Previous 13,599,837 55.6%
Holding current value
$1.16 Billion
Previous $1.45 Billion 73.4%
% of portfolio
0.17%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $765 Million - $1.26 Billion
7,561,448 Added 55.6%
21,161,285 $2.51 Billion
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $615 Million - $832 Million
7,206,486 Added 112.72%
13,599,837 $1.45 Billion
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $177 Million - $266 Million
2,549,779 Added 66.34%
6,393,351 $636 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $59.8 Million - $78.5 Million
-620,315 Reduced 13.9%
3,843,572 $397 Million
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $59.2 Million - $80.2 Million
499,693 Added 12.61%
4,463,887 $542 Million
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $36.5 Million - $53 Million
269,144 Added 7.28%
3,964,194 $609 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $183 Million - $325 Million
1,549,061 Added 72.18%
3,695,050 $664 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $66.2 Million - $109 Million
-560,665 Reduced 20.71%
2,145,989 $254 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $53.9 Million - $81.2 Million
459,992 Added 20.47%
2,706,654 $387 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $247 Million - $459 Million
-1,953,071 Reduced 46.5%
2,246,662 $387 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $714 Million - $1.16 Billion
-3,161,000 Reduced 42.94%
4,199,733 $1.07 Billion
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $32.3 Million - $70.6 Million
145,714 Added 2.02%
7,360,733 $2.83 Billion
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $937 Million - $1.7 Billion
7,215,019 New
7,215,019 $1.7 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.